NBR Show Clips

Morgan Brennan talks with Blue Origin CEO Bob Smith about the company’s new engine for its latest orbital rocket and new opportunities in space exploration

Morgan Brennan breaks down General Electric’s quarterly results.

As allergy season kicks into full swing, Meg Tirrell takes a look at what companies stand to benefit.

Our market monitor has names of stocks he says are winners in the digital economy.

China’s ZTE said that a U.S. ban on exports to the technology firm could threaten its survival and adversely affect American companies. Eunice Yoon reports.

Opioid prescriptions are on the decline in the U.S., according to a new report from the Iqvia Institute. But experts say the number is still too high.

Eunice Yoon takes a look at what’s driving growth at the world’s most valuable start-up focusing on artificial intelligence.

Researchers find that not only do funds of higher-testosterone managers produce lower returns, those managers also have a greater propensity to be terminated.

Julia Boorstin reports on the dramatic departure of the high-profile chief of the world’s largest advertising group.

The hot streak Philadelphia’s sports teams are experiencing is turning into a financial win for the City of Brotherly Love.

Phil LeBeau takes a look at how Allegiant’s stock was impacted by a blistering “60 Minutes” report that called into question the airline’s safety record.

Meg Tirrell takes a look at the advancements Merck is making in treating lung cancer.

Drug dealers are using bitcoin to finance the deadly wave of fentanyl flooding into the country from overseas. Ylan Mui follows the money from Main Street to the dark web to show how the cryptocraze allows drugs to get delivered right to your doorstep.

Our market monitor has a list of companies he says will benefit from strong economic growth and consumer spending.

Robert Frank reports on how some residents in high-tax states are transforming themselves into corporations to pay lower tax rates.